Who We Are

Biophagy is a new biopharmaceutical company, headquartered at The BioScience Center, Albuquerque, NM, USA.

Our management team includes seasoned pharmaceutical entrepreneurs,
business executives, and highly recognized scientists with extensive
academic credentials and publications in autophagy.

Our Team


What We Do

Biophagy’s corporate mission is to identify drugs that modulate autophagy
as part of a specific disease process.

In so doing we hope to relieve patient symptoms or halt disease progression in therapeutic areas with high unmet need. Biophagy anticipates that new therapeutic entities (NTEs), e.g., repurposed drugs, or new chemical entities (NCEs) identified through its proprietary technologies can act alone or as adjunct therapy with standard medical protocols.

The company expects to amass a significant portfolio of intellectual property, to develop companion diagnostics for personalized medicine, and to become a world leader in bringing autophagy modulators to the marketplace in several important therapeutic areas.